ABSTRACT. Understanding the mechanisms of controlled expansion and differentiation of basal progenitor cell populations during organogenesis is essential for developing targeted regenerative therapies. Since the cytokeratin 5-positive (K5 C ) basal epithelial cell population in the salivary gland is regulated by retinoic acid signaling, we interrogated how isoform-specific retinoic acid receptor (RAR) signaling impacts the K5 C cell population during salivary gland organogenesis to identify RAR isoform-specific mechanisms that could be exploited in future regenerative therapies. In this study, we utilized RAR isoform-specific inhibitors and agonists with murine submandibular salivary gland organ explants. We determined that RARa and RARg have opposing effects on K5
ABSTRACT. Understanding the mechanisms of controlled expansion and differentiation of basal progenitor cell populations during organogenesis is essential for developing targeted regenerative therapies. Since the cytokeratin 5-positive (K5 C ) basal epithelial cell population in the salivary gland is regulated by retinoic acid signaling, we interrogated how isoform-specific retinoic acid receptor (RAR) signaling impacts the K5 C cell population during salivary gland organogenesis to identify RAR isoform-specific mechanisms that could be exploited in future regenerative therapies. In this study, we utilized RAR isoform-specific inhibitors and agonists with murine submandibular salivary gland organ explants. We determined that RARa and RARg have opposing effects on K5
C cell cycle progression and cell distribution. RARa negatively regulates K5 C cells in both whole organ explants and in isolated epithelial rudiments. In contrast, RARg is necessary but not sufficient to positively maintain K5
C cells, as agonism of RARg alone failed to significantly expand the population. Although retinoids are known to stimulate differentiation, K5 levels were not inversely correlated with differentiated ductal cytokeratins. Instead, RARa agonism and RARg inhibition, corresponding with reduced K5, resulted in premature lumenization, as marked by prominin-1. With lineage tracing, we demonstrated that K5
C cells have the capacity to become prominin-1 C cells. We conclude that
INTRODUCTION
Retinoic acid, or all-trans retinoic acid (atRA), is a morphogen derived from Vitamin A that is important for the organogenesis of many systems, including the hematopoietic system, the brain, skin, lung, kidney, and the submandibular salivary gland (SMG). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] AtRA is generated following a two-step oxidation of vitamin A by retinol dehydrogenase (RDH) into the intermediate all-trans-retinal (atRAL); with the second oxidation by retinaldehyde dehydrogenase (RALDH) resulting in generation of atRA. AtRA is the primary physiological ligand for RAR, of which there are three main isoforms, alpha (RARa), beta (RARb) and gamma (RARg). Individual isoforms have both overlapping and distinct cellular effects, and differ in their ligand binding pockets and AF-2 domains such that selective pharmaceuticals can be used to target individual isoforms. 13 RARs function as transcription factors, heterodimerizing with retinoid X receptor (RXR), of which there are also three isoforms (a, b, g). RAR/RXR heterodimers bind DNA at defined retinoic acid response elements (RAREs) and affect transcription from target genes.
14 Previous studies have indicated that Vitamin A and RAR signaling are essential for development of many organs during embryogenesis. 3, 8, 15, 16 Characterization of RAR signaling during organogenesis is complicated by the requirement for retinoic acid signaling during embryonic development as lack of atRA causes widespread developmental defects and embryonic lethality. AtRA supplementation can subvert embryonic lethality in mice defective in atRA synthesis, including retinaldehyde dehydrogenase 2 (RALDH2) knock-out mice and retinol dehydrogenase 10 (RDH10) mutant mice, 17, 18 and withdrawal of atRA supplementation in RALDH2¡/¡ mice prevents lung development. 19 The importance of the RARa and RARg isoforms in developing salivary submandibular gland (SMG) was revealed with RARa and RARg double knockout mice that showed SMG developmental defects, including shortening of the main duct. 2, 3 Lineage analysis using a RA response-element (RARE)-driven Cre also indicated that the SMG responded to atRA during branching morphogenesis, 20 implying RAR functionality during early SMG organogenesis. To circumvent the need for atRA supplementation, a recent study interfered with atRA production using a RDH10 hypomorph, revealing decreased retinoic acid signaling in the developing SMG that was accompanied by decreased growth and branching morphogenesis. 8 A recent ex vivo study using a pan-RAR pharmacological antagonist to inhibit all RAR isoform activity in early SMG embryonic organ explants showed that decreased overall RAR signaling resulted in decreased branching morphogenesis and increased expression of the KRT5 gene. 9 Together, these studies indicate that retinoic acid has a critical role in SMG organogenesis and implicate RAR signaling in regulation of K5 C progenitor cells, however, RAR isoformspecific control of progenitor cell function during SMG development has not yet been identified.
Mouse SMG branching morphogenesis begins with protrusion of the oral epithelium into the surrounding mesenchyme at embryonic day 11 (E11), followed by formation of initial bud-onstalk structure at E12-E12.5. Development and differentiation proceed resulting in an arborized ductal system that terminates in secretory acini that produce saliva in the adult 21 . Elaboration of the gland structure depends upon the controlled proliferation and differentiation of progenitor cells. One SMG epithelial progenitor cell type is characterized by expression of cytokeratin 5 (K5), the K5 C population. Initially present in the majority of the cells in the placode, the K5 C population becomes ductally restricted, forming a basal layer in the large and intercalated ducts as development proceeds and in the adult 22, 23 . K5 is a marker of basal epithelial progenitor cells in several organs, including the mammary 24 and the salivary 25 glands. Cells of the K5 lineage were previously shown by lineage tracing to have the capacity to contribute to all epithelial cell types early in development of the submandibular gland, where their expansion was promoted by EGFR-dependent signaling from the parasymapathetic innervation 25 ; however, since K5 C cells persist in the absence of parasympathetic innervation, there are other uncharacterized regulators of this cell type.
In this study, we investigated the effects of RAR isoform-specific signaling on the distribution of K5
C cells in the mouse SMG during organogenesis. To directly examine RAR isoform-mediated signaling effects on the K5 C cells without impacts from global embryonic effects, we used ex vivo E12.5 submandibular salivary gland (SMG) organ explants that were treated with isoform-specific RAR inhibitors and agonists. We here report that RARa negatively regulates the abundance and the proliferation of K5 C cells. In contrast, RARg is necessary, but not sufficient, to positively maintain the accumulation and the proliferation of K5
C cells. The regulation of K5 C cells by both isoforms is independent of innervation. Additionally, RARa promotes the expression of prominin-1 (PROM-1) protein, a previously described SMG ductal lumenization marker [26] [27] [28] , without promoting differentiated ductal cytokeratins. Conversely, inhibition of RARg with a selective inhibitor also promoted PROM-1 without promoting increased ductal cytokeratins, consistent with a RARa-and RARg-induced decoupling of ductal differentiation from lumenization. We demonstrate that RARa and RARg have opposing effects on K5 C progenitor cell expansion and proliferation, and inversely promote lumenization during early submandibular salivary gland branching morphogenesis.
MATERIALS AND METHODS

Ex vivo gland culture
Embryonic day 12.5 glands were dissected from timed pregnant CD-1 mice (Charles River Laboratories, Wilmington, MA) with E0 defined as day of plug discovery following procedures approved by the University at Albany, SUNY IACUC committee. E12.5 glands were chosen to examine RAR isoform function during organogenesis, after both placode and organ anlage formation. Whole organ explants were placed on top of porous polycarbonate filters (Nuclepore, Whatman WHA110405) in MatTek dishes on serum-free 1:1 DMEM/Ham's F12 medium (F12) (Invitrogen 21041-025) containing penicillin (100 mg/ml), and streptomycin (100 mg/ml), ascorbic acid (150 mg/ mL) and transferrin (50 mg/mL) for 24 to 96 hours. For isolated epithelial rudiment experiments, epithelial rudiments were isolated via manual dissection following a mild 15 minute enzymatic digestion in dispase 0.4% v/v. Rudiments were then embedded in a Matrigel/DMEM (50% v/v) gel on top of a Nuclepore filter and cultured as described above with the addition of FGF-7 (200 ng/mL) (Peprotech) and EGF (20 ng/mL) (R&D Systems) to the culture media and cultured for 48 hours. Pharmacological antagonists were solubilized in vehicle (DMSO) in stock concentrations of 10 mM and were aliquoted, protected from light, and frozen at ¡20 C until use, including RARa inhibitor BMS195614 (Tocris), RARb inhibitor LE135 (Tocris), RARg inhibitor MM11253 (Tocris), RARa agonist AM80 (Tocris), and RARg agonist BMS961 (Tocris). RARg agonist CD1530 (Tocris) was made in an 8 mM stock in DMSO with 11.2 mM NaOH, aliquoted, protected from light, and frozen at ¡20 C until future use. 
Immunocytochemistry
Glands were fixed in either ice-cold methanol at ¡20 C or in 4% paraformaldehyde (w/v) (Electron Microscopy Sciences, Hatfield, PA) for 18 minutes, followed by two washes in 0.5% tween in phosphate buffered saline (PBS-T). We permeabilized paraformaldehyde-fixed tissues with 0.1% triton in PBS or 1% NP-40 in PBS, followed by washing in PBS-T. Blocking was then performed using 3% bovine serum albumin (BSA) (Sigma) in PBS. Primary antibodies diluted in 3% BSA in PBS (Table S1 ) were applied and incubated at 4C overnight. After washing in PBS-T, secondary antibodies were applied for 1-2 hours at room temperature (1:200 dilution, Jackson ImmunoResearch Laboratories, West Grove, PA). Samples were washed twice in PBS-T, and DAPI (Life Technologies) was applied for nuclear staining. Samples were washed an additional two times in PBS-T prior to mounting on slides. Images were obtained using matched laser settings on a Zeiss 710 confocal microscope.
DNA labeling
EdU labeling was performed using whole glands cultured for 48 hours, with EdU incorporated into the media during the final two hours of culture. Staining for EdU was completed using Click-it following manufacturer's recommendations, with the exception of an increased permeabilization step of 30 minutes (Thermo C10337). Samples were quantified from a minimum of 3 separate biological repeats.
Image quantification and statistical analysis
Measurements of markers within ductal epithelial area were performed using the open source software, FIJI 29 , to quantify positive pixel area of the marker of interest in confocal images relative to DAPI. Epithelial area was manually circled using the freeform lasso tool based on the presence of the characteristic layer of outer columnar cells surrounding the developing epithelial duct on DAPI-stained images, with the main duct identified as extending to the first ductal branch point. Regions of interest selected on the DAPI channel were saved and transferred to marker-containing channels. The total marker-positive area within that region was measured per channel after matched thresholding. Values were exported into Excel and graphed. Area of marker positivity was normalized to total ductal area per gland. Groups were averaged and graphed showing SEM. Sample size represents the number of explants quantified. A small number of explants were excluded from quantification due to physical damage to ducts during immunostaining based on pre-established criteria. Samples were quantified from a minimum of 3 separate biological repeats. Graphs were created using Microsoft Excel. Statistical analysis was performed using a two-tailed Student's t-test with VassarStats freeware 30 .
Western blot
Glands were lysed for total protein analysis in cold RIPA buffer (50 mM HEPES, 150 mM NaCl, 10% Glycerol, 1.5 mM MgCl, 1.5 mM EGTA, 1% Triton-100, 1% Na-deoxycholate, 0.1% SDS), with Roche protease and phosphatase inhibitor cocktails, (Thermo Sigma) and lysate was vortexed every ten minutes for 30 minutes followed by mild sonication. Highspeed centrifugation (13,300 £ g) was used to clear cell debris from the lysate, and the supernatant was used for further analysis. Lysate was processed into gel samples with 4x Laemmli Buffer (BioRad) with 5% b-mercaptoethanol (Sigma). Samples were run on precast gradient gels (BioRad cat#456-1086) with Tris/ Glycine/SDS buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3) (BioRad) and were transferred to PVDF membrane (GE Healthcare) in cold Tris/Glycine buffer (25 mM Tris, 192 mM glycine, pH 8.3) (BioRad). Blocking was performed rocking for 1 hour at room temperature using 5% milk in 0.5% tween in Tris buffered saline pH 7.6 (TBS-T). Primary antibody (Table S1 ) was applied in 4 mL of 0.1% milk in TBS-T at 1:1000 and incubated in 50 mL conicals at 4C overnight, rolling. After four 15 minute washes in TBS-T, HRP secondary antibody (GE Healthcare) was applied for 1-2 hours in 3% milk in TBS-T at room temperature, rolling. Blots were washed for an additional four washes in TBS-T and ECL (Pierce) was applied. Loading control GAPDH was subsequently applied at 1:10,000 in 4 mL of 3% milk in TBS-T for 1 hour at room temperature and processed as described above. Blots were imaged with X-ray film, scanned, and quantified using Quantity One software (BioRad). Sample size represents total number of Western blots, with each representing approximately 5-6 explants per group per blot. Groups were averaged and graphed using Microsoft Excel showing SEM. A two-tailed Student's t-test was performed using with VassarStats freeware 30 .
RNA extraction and qPCR
RNA was extracted from the glands using the Ambion RNAqueous Ò -4PCR kit, per the manufacturer's protocol. The extracted RNA was then treated with DNase I to eliminate any genomic contamination. PCR was performed on the DNase-treated RNA samples using Interleukin-2 genomic primers to confirm lack of genomic DNA contamination. The PCR reaction mixture was set up as shown in Table S2 and run in a GeneAmp PCR System 2400 thermocycler using the program described in Table S3 . All primers used are listed in Table S4 . The PCR samples were electrophoresed in a 1% agarose gel in a 1X TAE buffer (Tris-acetate-EDTA), pH of 8.3 and stained with 0.2 mg/mL of ethidium bromide. RNA was made into cDNA according to the New England Biolabs (NEB) First Strand cDNA Synthesis protocol using RNAse inhibitor (NEB), M-MuLV reverse transcriptase (NEB) and 10x stock M-MuLV buffer (NEB), 10 mM stock dNTP mix (NEB), and 100 mM stock oligo dT (IDT). Quantitative PCR was performed on the cDNA samples in a 384 well plate from Applied Biosystems using the Biorad CFX384 thermocycler. The reaction mixture was set up per the manufacturer's protocol using iQ SYBR Green Supermix (BioRad). The CFX384 thermocycler was run for 40 cycles, denaturing at 95 C and annealing/ extending at 65 C. All curves were normalized to the reference mRNA, GAPDH. Change in fluorescence was determined using the DDC q method 31 . Sample size represents biological replicates comprised of 5-6 explants per group, with each biological replicate run in technical triplicate then averaged. Values were graphed with SD in Microsoft Excel. Statistical analysis was performed using a two-tailed Student's ttest with VassarStats freeware 30 .
Lineage tracking using K5-CreERT2; ROSA26-TdTomato mice Hze /J mice (ROSA26-TdTomato) (Jackson Labs) overnight with day of plug identified as E0. Embryos were harvested at E12.5 and genotyped for Cre and TdTomato using primers detailed in Table S4 . K5Cre ERT2/C ; ROSA26-TdTomato SMG organ explants were placed on top of Nuclepore filters (Whatman WHA110405) in MatTek dishes on serum-free 1:1 DMEM/Ham's F12 medium (F12) (Invitrogen 21041-025) containing penicillin (100 mg/ ml), and streptomycin (100 mg/ml), ascorbic acid (150 mg/mL), and transferrin (50 mg/mL) and cultured for 72 hours. For K5-Cre induction, a pulse of 1 mM 4-OH tamoxifen (Sigma) solubilized in DMSO was incorporated into the RARa and RARg Reciprocally Control K5 C Progenitor Cell Expansion 5 media for the first four hours of culture. Culture media was rinsed and replaced for the remaining culture time.
RESULTS
RARa negatively regulates K5 C cells in developing salivary glands
To determine which isoforms of RAR are responsible for control of the K5 C population in the developing salivary gland, we manipulated RAR-mediated signaling in embryonic day 12.5 (E12.5) submandibular salivary gland organ explants cultured ex vivo. We manipulated the RAR isoforms independently with selective pharmacological inhibitors and agonists to assess their effects on K5
C cells after initial formation of the bud-on-stalk gland structure. Using immunocytochemistry (ICC) and confocal imaging, we first examined localization of RARa (Fig. S1 ). After verifying presence of RARa in the main duct, and after performing a dose response experiment (Fig. S2) , we used the RARa-specific inhibitor BMS195614 in E12.5 gland cultures. Using ICC and confocal imaging, we observed an expansion of K5 C progenitors in the main duct of RARa-inhibited glands, corresponding to an increased K5
C epithelial area following quantification (Fig. 1a, b) . Conversely, as first demonstrated in a dose response experiment (Fig. S2) , activation of RARa using the selective agonist AM80 in E12.5 gland cultures decreased the expansion of K5 C cells (Fig. 1a,  b) . Western blotting also indicated a significant increase in K5 protein levels in RARa-inhibited explants as compared to control, while RARa agonism led to a significant decrease in K5 levels (Fig. 1c, d ).
Since maintenance of K5 C cells during SMG development is dependent on muscarinic signaling from developing parasympathetic innervation 25 , retinoic acid signaling is known to directly regulate innervation 32 , and RA-dependent signaling was detected in embryonic submandibular salivary gland epithelium, parasympathetic ganglion neurons, and mesenchyme 9 , we questioned whether retinoic acid signaling acts directly on epithelial cells during early salivary gland development. Although Western analysis did not reveal a change in bIII tubulin levels with RARa inhibition (Fig.  S3) , to confirm that RARa function is intrinsic to the epithelium and independent of innervation, we cultured isolated epithelial rudiments, devoid of nerves and mesenchyme, in the presence and absence of the RARa isoform-selective inhibitor BMS195614, where we observed an increase in the K5 C epithelial area similar to results observed with whole glands (Fig. 1 e, f) . Together, these data indicate that RARa negatively regulates the expansion of K5
C progenitor cells, independently of innervation.
RARg positively regulates K5
C cells in developing salivary glands
We next examined the effect of RARg on the K5 C cell population. Immunostaining for RARg showed localization in the main duct in areas normally positive for K5
C cells (Fig. S1 ). Using the RARg-selective inhibitor MM11253, after performing a dose response experiment (Fig. S2) , with ICC and confocal imaging in E12.5 whole explant cultures we observed greatly decreased K5 C epithelial area (Fig. 2a, b ) and K5 levels by Western blotting (Fig. 2c, e) . Conversely, activation of RARg with the selective agonist CD1530, in accordance with the dose response experiment performed (Fig. S2) , showed no significant change in K5 C cell area in the main duct of the gland using ICC (Fig. 2a, b) and Western blotting (Fig. 2c, d) . Treatment of E12.5 explants in a separate experiment with another RARg specific agonist, BMS961, produced similar results (data not shown). Isolated epithelial rudiments cultured with the RARg-selective inhibitor MM11253 demonstrated reduced K5 expansion by ICC (Fig. 2e, f) . Since no significant change was observed in bIII tubulin levels by Western blot with RARg inhibition (Fig. S3) , taken together, these data show that positive regulation of the K5 cells by RARg is independent of innervation. Interestingly, manipulation of RARb with the RARb¡specific antagonist, LE135, did not affect the levels of K5 (data not 6 Desantis et al.
shown). We conclude that in contrast to RARa that negatively regulates the K5 C population, RARg positively regulates K5 C cells, also independently of innervation.
RARa negatively regulates cell cycle progression
To determine if regulation of cell proliferation contributed to changes in RARa-mediated levels of K5 in developing glands, we examined markers of cell cycle progression. Since Ki67 is present during all phases of the cell cycle except G 0 33 , we first analyzed Ki67 expression in ex vivo organ explants after 24 hours of treatment with the RARa-specific inhibitor BMS195614, where we observed that Ki67 mRNA expression was significantly increased as compared to control explants (Fig. 3a) . To quantify cells in S-phase, we incorporated EdU, a thymidine analog, into the media during the last two hours of culture followed by quantitative ICC in explants cultured for 48 hours 34 , which revealed a significant increase in EdU staining in the main ducts of RARa-inhibited glands where K5 C cells are concentrated (Fig. 3b, c) . To quantify cells in C ductal area relative to total ductal area with RARa inhibition shows significantly increased K5 C area. Scale bar 100 mm. Veh n D 12, a inhib n D 11 explants. Statistical analysis completed using Student's two-tailed t-test. *p D 0.045.
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C Progenitor Cell Expansion 7 C area normalized to total main duct area. Scale bar 100 mm. Veh n D 12 g inhib n D 11 explants. Statistical analysis completed using Student's two-tailed t-test. *** p D 0.0004. C area normalized to total main duct area. Veh n D 22, a ago n D 13, a inhib n D 9 explants. Statistical analysis completed using Student's two-tailed t-test. *p D 0.02.
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M-phase, we used quantitative ICC to examine phosphorylation of histone H3 (pHH3), which is phosphorylated on Ser10 specifically during mitosis 35 , where we observed a significant increase in pHH3 with RARa inhibition as compared to control (Fig. 3d, e) . Analysis of cleaved caspase 3 (CC3), an executioner caspase that is activated by cleavage by both extrinsic and intrinsic apoptosis pathways 36 , with quantitative ICC indicated that programmed cell death does not play a major role in changing K5 levels. The CC3-positive area is unchanged with decreasing levels of K5 observed with RARa agonism; however, the CC3-positive area is decreased significantly with the increasing K5 levels observed with RARa inhibition (Fig. S4) . These data are consistent with RARa negatively regulating cell cycle progression.
RARg positively regulates cell cycle progression
To determine if regulation of cell proliferation contributed to the changes in RARgmediated levels of K5 in developing glands, we examined markers of cell cycle progression. Using quantitative ICC, we examined S-phase with an EdU pulse and M-phase using pHH3 antibody. In RARg-inhibited explants grown for 48 hours with EdU incorporated into the media for the final two hours, we observed a significant decrease in EdU staining in the main duct relative to vehicle control-treated glands (Fig 4a, c) . Additionally, we observed significantly reduced pHH3 levels in the main duct (Fig. 4b, d ). Like manipulation of RARa, changes in CC3 staining with manipulation of RARg signaling was not correlated with changes in K5 expansion, showing no significant change in RARg agonism, while RARg inhibition significantly decreased CC3 staining in the main duct (Fig. S4) . In contrast to RARa, these results suggest that RARg positively regulates cell cycle progression, and RARg inhibition leads to cell cycle arrest in early developing salivary glands, consistent with loss of K5 expression.
RAR isoforms reciprocally regulate lumenization of the primary duct
Since retinoic acid is known to stimulate differentiation 6,37-39 and since K5 C cells acquire expression of K19 as the ductal epithelia mature and differentiate along the ductal lineage 25 we next examined if manipulation of RAR isoforms influenced ductal differentiation using quantitative ICC for K19. In conditions previously shown to decrease K5 levels, such as RARa agonism and RARg inhibition, decreased K5 levels correspond with decreased K19 levels; however, K19 expression was not absent (Fig. 5a-c) . Increased K5 levels seen in RARa inhibition and RARg agonism, however, corresponded with no significant change in K19 (Fig. 5a-c) . Taken together, these results indicate that decreased levels of K5 correspond to decreased K19, regardless of isoform-specificity, consistent with a loss of K5 C progenitor cells leading to a loss of downstream K19 C ductal differentiation. However, our data indicate that neither RARa nor RARg specifically regulate duct-specific cytokeratin expression during ductal differentiation.
As both epithelial maturation and lumenization occur during the development of the salivary duct, we next examined the effect of isoform-specific RAR signaling on the presence of PROM-1, an apical lumenizing surface marker of the ductal epithelium in the salivary gland and other stratified epithelia [26] [27] [28] . Using quantitative ICC of E12.5 explants cultured under conditions resulting in decreased K5, (i.e. RARa agonism and RARg inhibition), significantly increased PROM-1 levels were observed within the main duct (Fig. 5d, e) . PROM-1 was relatively absent in conditions corresponding to increased K5, including RARa inhibition and RARg agonism (Fig. 5d,  e) . Lineage tracking using tamoxifen inducible K5Cre ERT2/C ; ROSA26-TdTomato mice indicated that in cultured E12.5 explants, PROM-1 and TdTomato co-localize in a subset of cells after a short pulse of tamoxifen at the start of culture to induce Cre expression in K5
C cells (Fig. 5 f) , demonstrating that K5
C cells have the capacity to become PROM-1 expressing cells. Taken together, these results indicate that signaling through RARa restricts K5
C cell expansion and promotes lumenization, while RARg signaling promotes K5
C cell expansion and negatively regulates lumenization.
DISCUSSION
Many FDA-approved pharmaceuticals target nuclear receptors, including estrogen receptor (ER), progesterone receptor (PR), glucocorticoid receptor (GCR), peroxisome proliferatoractivated receptor (PPAR), RAR, and others, although the exact pharmaceutical mechanisms of action or isoform specificity in some cases is unknown due to unresolved receptor activity or use of pan-receptor ligands. Although in vivo RAR isoforms bind identical ligands, biochemical characterization revealed differences in isoform ligand binding domain sequences, allowing for design of synthetic isoform-specific retinoid agonists and inhibitors 40 . In regenerative therapies, atRA initially demonstrated the capacity to regenerate alveoli in rat 41 and mouse 42 . After demonstrating efficacy in a human case study where atRA was used to initiate regeneration after damage from emphysema 43 , clinical trials using atRA were C area normalized to total main duct area. Veh inhib n D 22, g inhib n D 15 explants. Statistical analysis completed using Student's two-tailed t-test. *p D 0.04. Taken together, these results suggest G1 mediated cell cycle arrest.
RARa and RARg Reciprocally Control K5
C Progenitor Cell Expansion 11 completed 44, 45 . Retinoids are FDA approved for topical application in the form of tretinoin, and synthetic Tazarotene (AGN 190299), and are currently in Phase I and II clinical trials used alone and in combination for several conditions including breast carcinoma (Phase Ib NCT02876640) and multiple myeloma (Phase I and II NCT02751255). However, use of atRA as a pan-RAR agonist has not been entirely successful. Initial trial results using atRA to induce lung regeneration indicated that atRA was unsuccessful in improving patient lung conditions or function 44 . Recent studies have begun targeting RARs in an isoform-specific manner using isoform-specific pharmacological agonists and inhibitors for improved selectivity and function. Regenerative studies in skeletal muscle in the mouse have recently demonstrated that selective receptor isoform agonism of RARg improved muscle regeneration 46 , as well as moving to RARg isoform-selective Phase I and Phase II trials in lung regeneration 47 , clinical trials achieving positive results yet limited by small patient cohort 48 . Targeting of specific RAR isoforms has not yet been tested as a strategy for salivary gland regeneration; however, our results indicate that the behavior of K5 C cells is under complex control by RARs during development.
In this study, we examined isoform-specific RAR effects on SMG organogenesis in organ explants to investigate RAR isoform-specific control of K5 C progenitor cells during development with the intent to inform future salivary gland regenerative therapies. We report that during organogenesis, RARa and RARg have opposing effects on cell cycle progression and expansion of K5 C cells, in that RARa negatively regulates cell cycle progression and K5 C expansion, while RARg positively regulates cell cycle progression and K5
C cell expansion. Inhibition of pan-RAR signaling in embryonic SMG organ explants was recently shown to inhibit cell proliferation and reduce FGFdependent signaling during branching morphogenesis while transcriptionally upregulating K5, independent of innervation 9 . Here, we have isolated the impacts of individual RAR isoforms on cell cycle and K5
C cell distribution, uncovering that RARa and RAR have antagonizing effects on cell cycle progression and K5
C progenitor cell expansion. Our data cannot ;ROSA26-TdTomato mice cultured ex vivo for 68 hours following a four hour tamoxifen induction (1 mM) shows TdTomato reporter expression (white) in a handful of PROM-1 (red) positive cells in the main duct (yellow arrows), with ECAD (green) and DAPI (blue), indicating that these cells were derived from the K5 lineage. Scale bar, 50 mm. discriminate whether the expansion of K5 C cells during early SMG development results from expansion of existing K5
C progenitors, progressive specification of K5 C progenitors, or both, at this stage of development. Nevertheless, we have shown that accumulation of K5 C cells is dependent on RAR isoform-specific signaling, and our results imply that the previously reported expansion of K5
C cells with pan-RAR inhibitor 9 is due primarily to manipulation of RARa. Thus for future therapeutic restoration of salivary gland function, inhibition of endogenous RARa function may be effective to expand K5
C progenitor cells, whereas RARg may not be an effective clinical target for progenitor cell expansion, suggesting that RARa inhibitors will be superior to pan-RAR modulation for restoration of impaired salivary function.
Controlled regulation of the cell cycle is important for proper differentiation during development 37, 49, 50 , while in other contexts differentiation impacts cell cycle progression. Retinoic acid is well known to induce differentiation downstream of cell cycle arrest through tissue-specific mechanisms 38, 51 . Interestingly, we did not detect an associated change in differentiation of K5 C cells into K19 C ductal cells with RAR-mediated manipulation of the cell cycle, indicating that RAR-induced manipulation of cell proliferation does not necessarily lead to keratin-marked differentiation,
RARa and RARg Reciprocally Control K5 C Progenitor Cell Expansion 13 consistent with recently published data that RAR signaling does not affect keratin-marked differentiation in salivary glands 9 . These data are also consistent with atRA manipulation of keratinocytes, where atRA administration decreased both basal and suprabasal cytokeratins 52 . Interestingly, we did observe premature ductal lumenization with RARa agonism or RARg inhibition. During SMG development, signaling through RARg may normally restrict ductal lumenization to counterbalance lumenizing signals provided by RARa, providing fine control over timing of ductal lumenization during normal development. The lack of correlation between the lumenizing marker, PROM-1, with the ductal marker, K19, with RAR manipulation indicates that keratin-marked ductal fate and cell lumenization are uncoupled events during ductal development. Importantly, K19 levels did not decrease with retinoid-expanded K5 levels, and lineage tracking revealed K5 C cells can acquire the PROM-1 lumenization marker with normal development, indicating that the expanded K5
C progenitor cells can differentiate into PROM-1 C duct cells. Together, these data suggest that isoform-specific RARa inhibition holds promise for clinical application to expand K5
C endogenous progenitor cells to enhance salivary gland regeneration and restore function in patients suffering from salivary hypofunction.
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